Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, January 10, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Technology
Etiometry Highlights AI Platform Gains as Hospitals Face Rising Operational Pressures
Life Sciences Times
-
January 8, 2026
0
Technology
Elemental Machines Launches Agentic AI Platform to Drive Autonomous Decision-Making in Life Sciences Operations
Life Sciences Times
-
January 8, 2026
0
Pharma
Amylyx Selects AMX0318 as Development Candidate for Post-Bariatric Hypoglycemia and Rare Diseases
Life Sciences Times
-
January 8, 2026
0
People on the Move
AstraZeneca Names Rick R. Suarez US President and Head of US BioPharmaceuticals Unit
Life Sciences Times
-
January 8, 2026
0
Venture Capital
Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform
Life Sciences Times
-
January 8, 2026
0
People on the Move
Tubulis Names Charles Fuchs, M.D. as Chief Medical Officer to Lead Clinical Strategy
Life Sciences Times
-
January 8, 2026
0
Biotech
Cellino and Polyphron Partner to Scale Personalized Tissue Replacement Manufacturing
Life Sciences Times
-
January 8, 2026
0
Biotech
BostonGene Partners With Ottimo Pharma to Advance AI-Guided Development of PD-1/VEGFR2 Cancer Therapy
Life Sciences Times
-
January 8, 2026
0
Venture Capital
Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth
Life Sciences Times
-
January 8, 2026
0
People on the Move
Charles River Laboratories Names Birgit Girshick as Next CEO as James C. Foster Plans Retirement
Life Sciences Times
-
January 8, 2026
0
1
2
3
...
782
Page 2 of 782
Most Popular
Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases
January 9, 2026
GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform
January 9, 2026
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
January 9, 2026
Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition
January 9, 2026
Load more
Recent Comments
Recent Comments